These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 24758626)
21. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study. Golub JE; Cohn S; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; Durovni B; Chaisson RE Clin Infect Dis; 2015 Feb; 60(4):639-45. PubMed ID: 25365974 [TBL] [Abstract][Full Text] [Related]
22. Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study. Bachhuber MA; Gross R Int J Tuberc Lung Dis; 2009 Aug; 13(8):1038-40. PubMed ID: 19723386 [TBL] [Abstract][Full Text] [Related]
23. Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec; 1999 Nov; 74(46):385-98. PubMed ID: 10611855 [No Abstract] [Full Text] [Related]
24. [Cost effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings]. Yoshiyama T Kekkaku; 2000 Nov; 75(11):629-41. PubMed ID: 11140086 [TBL] [Abstract][Full Text] [Related]
25. Isoniazid prophylaxis against tuberculosis in children. Zar HJ; Lombard C N Engl J Med; 2011 Oct; 365(16):1543; author reply 1543-4. PubMed ID: 22010924 [No Abstract] [Full Text] [Related]
27. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Chaisson RE; Barnes GL; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore RD Am J Med; 2001 Jun; 110(8):610-5. PubMed ID: 11382368 [TBL] [Abstract][Full Text] [Related]
28. Isoniazid to prevent first and recurrent episodes of TB. Ayles H; Muyoyeta M Trop Doct; 2006 Apr; 36(2):83-6. PubMed ID: 16611439 [No Abstract] [Full Text] [Related]
29. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care. Tram KH; Mwangwa F; Atukunda M; Owaraganise A; Ayieko J; Plenty A; Kwariisima D; Clark TD; Petersen ML; Charlebois ED; Kamya MR; Chamie G; Havlir DV; Marquez C; J Acquir Immune Defic Syndr; 2017 Dec; 76(5):e115-e117. PubMed ID: 28885271 [No Abstract] [Full Text] [Related]
30. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia. Foster S; Godfrey-Faussett P; Porter J AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218 [TBL] [Abstract][Full Text] [Related]
36. For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance. Cobelens FG Sci Transl Med; 2013 Apr; 5(180):180fs12. PubMed ID: 23576813 [TBL] [Abstract][Full Text] [Related]
37. Question from the clinician: tuberculosis prophylaxis. Wald E Pediatr Rev; 2003 Oct; 24(10):355. PubMed ID: 14523162 [No Abstract] [Full Text] [Related]
38. Protecting young healthcare trainees from tuberculosis: can we overcome apathy? Pai M; Christopher DJ Natl Med J India; 2011; 24(4):198-200. PubMed ID: 22208137 [No Abstract] [Full Text] [Related]
39. No effect of isoniazid prophylaxis for purified protein derivative-negative HIV-infected adults living in a country with endemic tuberculosis: results of a randomized trial. Fitzgerald DW; Severe P; Joseph P; Mellon LR; Noel E; Johnson WD; Pape JW J Acquir Immune Defic Syndr; 2001 Nov; 28(3):305-7. PubMed ID: 11694842 [No Abstract] [Full Text] [Related]
40. Isoniazid prophylaxis in end-stage renal disease. Bal AM Transpl Infect Dis; 2006 Dec; 8(4):242-3; author reply 243. PubMed ID: 17116141 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]